Publication details

Analysis of serum lipids, cardiovascular risk and indication for statin therapy at the start and during imatinib and nilotinib therapy in de novo CML patients, results from real life prosective study

Authors

HORŇÁK Tomáš SEMERÁD Lukáš ŽÁČKOVÁ Daniela WEINBERGEROVÁ Barbora ŠUSTKOVÁ Zuzana PROCHÁZKOVÁ Jiřina MAYER Jiří RÁČIL Zdeněk

Year of publication 2018
Type Conference abstract
Citation

You are running an old browser version. We recommend updating your browser to its latest version.

More info